Form 4: Hims & Hers CEO Andrew Dudum Executes Stock Sales and Transfers Under 10b5-1 Plan

Sentiment:

SEC Form 4


Hims & Hers CEO Andrew Dudum sold 33,513 shares of Class A Common Stock and transferred shares between various trusts, according to a recent SEC filing.

Summary

  • Andrew Dudum, CEO of Hims & Hers Health, Inc., executed a sale of 33,513 shares of Class A Common Stock at an average price of $33.3797 per share.
  • The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 28, 2024.
  • The shares were sold at varying prices between $33.07 and $33.80.
  • Dudum also transferred shares of Class A Common Stock between several trusts, including the Andrew Dudum 2015 Trust and various GRATs (Grantor Retained Annuity Trusts).
  • These transfers involved annuity payments-in-kind from the GRATs to the Andrew Dudum 2015 Trust.
  • The filing also details the beneficial ownership of Class V Common Stock, which is convertible into Class A Common Stock under certain conditions.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing insider transactions. While the stock sale might cause minor concern, the use of a 10b5-1 plan suggests it was pre-planned and not based on any new negative information. The transfers between trusts are standard practice for estate planning.

Risks

  • The sale of shares by the CEO could be perceived negatively by the market, potentially impacting the stock price.
  • The complex structure of trusts and transfers may raise questions about insider activity.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The use of 10b5-1 plans is a standard practice for executives to manage their stock sales while avoiding accusations of insider trading.

Comparison to Industry Standards

  • The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the healthcare and technology sectors, such as Teladoc Health and GoodRx.
  • The structure of trusts and GRATs is also a standard method for managing personal finances and estate planning for high-net-worth individuals, similar to practices seen at companies like Amazon and Google where executives use similar methods.
  • The volume of shares sold is relatively small compared to the total outstanding shares, which is typical for routine insider sales.

Stakeholder Impact

  • The stock sale by the CEO could potentially cause a slight negative reaction from shareholders, although the use of a 10b5-1 plan mitigates this risk.
  • The transfers between trusts are unlikely to have a direct impact on other stakeholders.

Key Dates

DateDescription
2015-07-02Date of the Andrew Dudum 2015 Trust.
2021-01-20Date of the New Hims Certificate of Incorporation.
2021-08-10Date of the Dudum Family Heritage Trust UAD.
2021-11-01Date of the AD 2021 GRAT and AD 2021 GRAT 2.
2022-09-07Date of the AD 2022 GRAT 2.
2022-11-28Date of the AD 2022 GRAT 3.
2023-09-05Date of the AD 2023 GRAT.
2024-08-28Date the Rule 10b5-1 trading plan was adopted.
2024-12-02Date of the reported stock sale and transfers.
2024-12-03Date of the SEC filing.

Keywords

Hims & Hers, Andrew Dudum, SEC Form 4, stock sale, Rule 10b5-1, insider trading, Class A Common Stock, Class V Common Stock, GRAT, trust

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.